Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Trio Combination vs Kligman's Formula for Melasma
NCT07676994Phase 4Completed
- Sponsor
- Ghurki Trust and Teaching Hospital
- Start
- May 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, randomised trial in melasma (2 arms), sponsored by Ghurki Trust and Teaching Hospital. Primary endpoints: Melasma Quality of Life at 12 weeks and modified Melasma Area and Severity Index at 12 weeks. Started May 2025; status: completed.
02
Conditions
melasma
Beyond the preview
Go deeper on NCT07676994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07676994.